BioPharmSignal logoBioPharmSignal

Biotech News

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

Progyny (PGNY)ProgynyCompany update

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- A new survey from Progyny (Nasdaq: PGNY), a global leader in women’s health and family building solutions, found that people

Related news

PGNYProgyny2026-09-03 15:17 EST

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

PGNYProgyny2026-01-12 13:00 EST

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

TDOCTeladoc2026-03-30 20:30 EST

Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors

MGRXMANGOCEUTICALS2025-12-19 12:30 EST

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

HSTMHealthStream2026-09-14 13:25 EST

HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)

TDOCTeladoc2026-07-23 10:00 EST

Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care

SERASera Prognostics2026-06-24 20:05 EST

SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH

HSTMHealthStream2026-03-26 13:25 EST

Virsys12® Named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment

FEMYFEMASYS2026-02-23 14:00 EST

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination

COOThe Cooper Companies2025-12-29 21:15 EST

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-11-04 21:01 EST

Progyny, Inc. Announces Third Quarter 2026 Results

PGNYProgyny2026-10-28 13:52 EST

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

PGNYProgyny2026-10-26 15:25 EST

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-10-15 13:35 EST

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Stock data

Close
34.37 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States